These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 793117)

  • 21. Characterization of a serum inhibitor of MLC reactions.
    Gatti RA; Yunis EJ; Good RA
    Clin Exp Immunol; 1973 Mar; 13(3):427-37. PubMed ID: 4144968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 23. Further studies of genetic histocompatibility determinants in conditioning the fate of bone marrow allografts in selectively bred dogs.
    Ayvazian JH; Bachvaroff R; Cannon FD; Mollen N; Blumenstock DA; Ferrebee JW; Rapaport FT
    Transplant Proc; 1973 Dec; 5(4):1775-9. PubMed ID: 4130082
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidonor immunologic reactions of long-standing radiation chimeras.
    van Bekkum DW; Roodenburg J
    Transplant Proc; 1973 Mar; 5(1):881-6. PubMed ID: 4572150
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe combined immunodeficiency treated with bone marrow graft.
    Robinson JE
    Proc R Soc Med; 1975 Sep; 68(9):583-4. PubMed ID: 1105600
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction and paralysis: a conceptual framework from which to examine the intestinal immune system.
    Kagnoff MF
    Gastroenterology; 1974 Jun; 66(6):1240-56. PubMed ID: 4597753
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid and immunologic status of dogs with perianal fistula.
    Killingsworth CR; Walshaw R; Reimann KA; Rosser EJ
    Am J Vet Res; 1988 Oct; 49(10):1742-6. PubMed ID: 3189991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parameters of allogeneic unresponsiveness in canine radiation chimerae, with particular reference to the possible existence of three closely linked genetic systems relevant to bone marrow transplantation.
    Rapaport FT; Ozaki A; Cannon FD; Mollen M; Blumenstock D; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1973 Mar; 5(1):845-52. PubMed ID: 4572147
    [No Abstract]   [Full Text] [Related]  

  • 29. Relations of HL-A and Rh systems to immune reactivity. Joint report of the results of 'HL-A and immune response' workshop, Budapest 1972.
    Vox Sang; 1974; 26(5):470-82. PubMed ID: 4210390
    [No Abstract]   [Full Text] [Related]  

  • 30. The primary immunodeficiency diseases: classification, pathogenesis and treatment.
    Gatti RA; Seligmann M
    Turk J Pediatr; 1973 Oct; 15(4):195-215. PubMed ID: 4600502
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance manifestations among inbred rat strains defined in the rt H-1 antigens. II. Specific depression of antibody production in rats surviving the neonatal administration of allogeneic cells and rejecting the donor skin graft.
    Kren V; Krenová D; Stark O
    Folia Biol (Praha); 1970; 16(2):89-101. PubMed ID: 4908856
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergy between injection of F1 spleen cells and thymectomy on maintenance of skin allograft tolerance in adult recipient mice treated with supralethal irradiation followed by syngeneic bone marrow cell transplantation.
    Tomita Y; Mayumi H; Nomoto K
    Transplant Proc; 1990 Feb; 22(1):251-6. PubMed ID: 2137950
    [No Abstract]   [Full Text] [Related]  

  • 33. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine radiation chimeras: an attempt to demonstrate serum blocking factors by an in vivo approach.
    Schroeder ML; Storb R; Graham TC; Weiden PL
    J Immunol; 1975 Feb; 114(2 Pt 1):540-1. PubMed ID: 1091700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 36. Allogeneic inhibition in tolerant animals.
    Möller E; Lapp W; Lindholm L
    Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
    [No Abstract]   [Full Text] [Related]  

  • 37. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 38. The recovery of the B-cell population in adult thymectomized, lethally irradiated and bone marrow-reconstituted mice.
    van Muiswinkel WB; van Beek JJ; van Soest PL
    Immunology; 1975 Aug; 29(2):327-36. PubMed ID: 1099000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.
    Kolb HJ; Storb R; Weiden PL; Ochs HD; Kolb H; Graham TC; Floersheim GL; Thomas ED
    Biomedicine; 1974 Sep; 20(5):341-51. PubMed ID: 4615750
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of hydrocortisone on the immune response.
    Cohen JJ
    Ann Allergy; 1971 Jul; 29(7):358-61. PubMed ID: 4398551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.